DER AKTIONÄR – Unsere App
SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 (ENGLISCH)
^
EQS-News: SHOP APOTHEKE EUROPE N.V. / Schlagwort(e): Hauptversammlung
SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING
OF SHAREHOLDERS 2023 (ENGLISCH)
15.03.2023 / 18:34 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
---------------------------------------------------------------------------
HINWEIS: DIESE MITTEILUNG IST NUR IN ENGLISCHER SPRACHE VERFÜGBAR.
NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO
THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.
SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING
OF SHAREHOLDERS 2023
Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or
the "Company") has today published the convocation for the annual general
meeting of shareholders of the Company to be held on 26 April 2023 (the
"AGM").
The AGM materials (including the convocation notice, the agenda with the
explanatory notes thereto as well as other relevant documentation) are
available on the corporate website of the Company (
http://shop-apotheke-europe.com) under Investor Relations / General Meeting
/ Annual General Meeting 2023 and via the link:
http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/
Among other things, shareholders at this year's AGM will vote on the
Company's name change, the appointment of a new CEO and the 2022 Annual
Report.
The AGM is scheduled to take place on 26 April 2023 starting at 10:00 CEST,
and will take place as a hybrid meeting, meaning that shareholders are given
the option to either participate in the AGM (i) in person at the Company's
headquarters, Erik de Rodeweg 11-13, Sevenum, the Netherlands or (ii)
virtually, through the online platform provided by the Company's service
provider Better Orange IR & HV AG (such platform the "Online Platform").
Taking into consideration that the Covid-19 virus may still pose a health
risk for shareholders and employees of the Company, the Company strongly
encourages its shareholders to take part in the AGM via the Online Platform
and not to attend the AGM in person.
For further information please contact us at:
General AGM related matters:
Rens Jan Kramer
Telephone: +31 6 46 18 67 23
Email: rensjan.kramer@shop-apotheke.com
Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: presse@shop-apotheke.com
Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com
---------------------------------------------------------------------------
15.03.2023 CET/CEST Veröffentlichung einer Corporate News/Finanznachricht,
übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate
News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
---------------------------------------------------------------------------
Sprache: Deutsch
Unternehmen: SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Niederlande
Telefon: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-Mail: Investor.Relations@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indizes: SDAX
Börsen: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart, Tradegate Exchange
EQS News ID: 1583661
Ende der Mitteilung EQS News-Service
---------------------------------------------------------------------------
1583661 15.03.2023 CET/CEST
°
Quelle: dpa-AFX
